Fonte: EMBO Molecular Medicine. Unidade: IQ
Assuntos: NEURÔNIOS, ORGANELAS CELULARES, CÉLULAS-TRONCO
ABNT
TRUJILLO, Cleber A et al. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids. EMBO Molecular Medicine, v. 13, p. 1-18 art. e12523, 2021Tradução . . Disponível em: https://doi.org/10.15252/emmm.202012523. Acesso em: 02 out. 2024.APA
Trujillo, C. A., Adams, J. W., Negraes, P. D., Carromeu, C., Tejwani, L., Acab, A., et al. (2021). Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids. EMBO Molecular Medicine, 13, 1-18 art. e12523. doi:10.15252/emmm.202012523NLM
Trujillo CA, Adams JW, Negraes PD, Carromeu C, Tejwani L, Acab A, Tsuda B, Thomas CA, Sodhi N, Fichter KM, Romero S, Zanella F, Sejnowski TJ, Ulrich H, Muotri AR. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids [Internet]. EMBO Molecular Medicine. 2021 ; 13 1-18 art. e12523.[citado 2024 out. 02 ] Available from: https://doi.org/10.15252/emmm.202012523Vancouver
Trujillo CA, Adams JW, Negraes PD, Carromeu C, Tejwani L, Acab A, Tsuda B, Thomas CA, Sodhi N, Fichter KM, Romero S, Zanella F, Sejnowski TJ, Ulrich H, Muotri AR. Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids [Internet]. EMBO Molecular Medicine. 2021 ; 13 1-18 art. e12523.[citado 2024 out. 02 ] Available from: https://doi.org/10.15252/emmm.202012523